Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

prostate cancer, prostate cancer (adenocarcinoma), prostate cancer metastatic disease, prostate cancer recurrent, prostate carcinoma, prostate neoplasm, prostate adenocarcinoma, prostate cancer with bone metastasis, vasomotor disturbance, vasomotor symptoms, vasomotor symptoms (vms), vasomotor symptoms as a sex hormone-dependent disorder in women and men